Ovarian cancer, the coagulation pathway, and inflammation
about
Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7Platelet effects on ovarian cancerDeriving a mutation index of carcinogenicity using protein structure and protein interfacesDifferential prioritization between relevance and redundancy in correlation-based feature selection techniques for multiclass gene expression data.Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study.Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.Clinical significance of coagulation factors in operable colorectal cancer.Improved in vitro blood compatibility of polycaprolactone nanowire surfaces.Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen.Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic diseaseEarly inflammatory response in epithelial ovarian tumor cyst fluids.A computational approach to identifying gene-microRNA modules in cancer.The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational studyIdentification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset.Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis.Cytokines and Prognostic Factors in Epithelial Ovarian Cancer.Depression, social support, and beta-adrenergic transcription control in human ovarian cancerRelationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer.Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment.Chemokines, chemokine receptors and CD4+CD25+ regulatory T cells.Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.MODELING DEPENDENT GENE EXPRESSIONProinflammatory signaling functions of thrombin in cancer.Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.Functional expression of the chemokine receptor XCR1 on oral epithelial cells.Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis.Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.Effects of introducing fibrinogen Aalpha character into the factor XIII activation peptide segment.Thrombin promotes epithelial ovarian cancer cell invasion by inducing epithelial-mesenchymal transition.The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression.Expression and shedding of endothelial protein C receptor in prostate cancer cells.Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma - a multicenter study.
P2860
Q24674282-FADD6214-769F-457C-A04E-E886B2F15444Q26829401-AADFB9B4-1B5A-4AF1-9F63-0DD956415D03Q28538696-A58BE898-E852-4D3D-85DD-E4D821C3E745Q30478009-88BEB1D0-8D54-4F03-A2C1-2D65579297DBQ33563950-78A64AC2-A084-476D-8677-4636C6135B2DQ33616584-D31502AE-AD03-4207-94C8-535AD3513CE6Q33622587-33A77587-A81F-4062-BAF1-51B3137E4CBAQ33750966-12B35240-2E6E-4153-BDDE-684DF55C5793Q34237615-2C426148-7991-4529-8D1E-92DB3837A595Q34361335-ECF2CC6C-54F1-4951-974F-1C60D9019670Q34887528-45E6F492-F438-461F-8450-8009C4199E34Q34997791-8056AF01-39E9-42FA-95FC-0082C3C86012Q34998539-36CE65B2-AF4F-4C0F-8E87-7F02EFDFBE04Q35547227-52F90261-A2B1-4395-83A5-79348A31370DQ35678382-5937D159-9BB6-4AF2-811D-4AAE8939101CQ35790450-062026BC-735D-4E25-BF79-21BB0013EE1EQ35905939-7E4FB728-546F-4E23-9516-C8D3BDC7E42EQ36640047-8D11B14F-7A51-476F-ACFB-DD6AB232AF8AQ36640430-31DC6CEC-11A2-4CBE-9A87-20B4ACD74772Q36715028-C336D882-9E87-41C0-9AB3-D62306367C41Q36730586-187F1476-1ECB-4217-A690-DAE81DF80821Q37088527-8428EAEE-5540-4580-B692-33E2081452EBQ37152508-9E4325DB-9AF0-4330-B737-973F42D00BB9Q37180148-5C887E8A-DBBD-4CD9-AAEF-8FA181D298B2Q37259580-C13C7802-1646-4023-B9F9-042586CFFDF8Q37313286-BD846C99-B1E1-44F5-80B3-D38F32FA9394Q37709136-056A4A67-1A16-40FC-9017-BD5B509637B2Q37755313-3C120595-AA31-455B-8493-00DA3E063D6DQ38184632-0BC58FEE-54EB-4AD1-BB7D-5AFF97D9DCD4Q38803187-7501598B-6A2E-4B26-BA53-824439E89DB4Q39048394-EB97F408-42D4-4D27-9E87-7918AFB40750Q39683672-B9A20845-3E34-444B-A25C-4F0B8A258B84Q39728503-E1A10F9E-069B-4654-954C-4757D953219EQ40274074-A6FF339A-D014-449E-80E1-837DC7322641Q40447303-C615F85D-14AB-47A7-983D-F7DB04448A70Q41786155-3047700D-B9CC-4A02-B1BE-CB7E6E5B6482Q41834364-19EB53C6-C95D-4C55-82EC-5AABB2D2A107Q42161605-ECFD27DB-3B65-43B3-9156-83F344406859Q42239302-B0C8AA75-7D39-4566-9B0F-5ED0BCA1277FQ43621266-570CCB92-2619-4C41-8B78-D43FA61CFE4E
P2860
Ovarian cancer, the coagulation pathway, and inflammation
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Ovarian cancer, the coagulation pathway, and inflammation
@ast
Ovarian cancer, the coagulation pathway, and inflammation
@en
Ovarian cancer, the coagulation pathway, and inflammation
@nl
type
label
Ovarian cancer, the coagulation pathway, and inflammation
@ast
Ovarian cancer, the coagulation pathway, and inflammation
@en
Ovarian cancer, the coagulation pathway, and inflammation
@nl
prefLabel
Ovarian cancer, the coagulation pathway, and inflammation
@ast
Ovarian cancer, the coagulation pathway, and inflammation
@en
Ovarian cancer, the coagulation pathway, and inflammation
@nl
P2093
P2860
P3181
P356
P1476
Ovarian cancer, the coagulation pathway, and inflammation
@en
P2093
John J Kavanagh
Ralph S Freedman
Xipeng Wang
P2860
P2888
P3181
P356
10.1186/1479-5876-3-25
P407
P577
2005-06-21T00:00:00Z
P5875
P6179
1029874910